Another stock that could have a lot more life in it, is Regeneron. This is a $410 biotech stock that has rallied 49 percent year-to-date.
"For those of you who are sitting on the sidelines telling yourself that Regeneron has run up way too much, that you missed it and it's just insanely risky to buy something after such an epic move, I'm telling you that the upside here is far from over," Cramer said.
The "Mad Money" host initially recommended this stock as one of the four horsemen of the big pharma apocalypse in his book "Get Rich Carefully," and he thinks it is not too late to pull the trigger on this one.
The company has three blockbusters in its pipeline that could signal growth. The first is Dupilumab, a treatment for atopic dermatitis; second is Alirocumab, an anti-cholesterol drug; and the third is Sarilumab, for rheumatoid arthritis.
If they receive FDA approval, then they could provide peak sales potential of more than $11 billion. So while this stock is not exactly cheap, it certainly isn't a one-trick pony.
"I think it's worth putting on a small position right now just in case we don't get any weakness," Cramer recommended.
One thing that really gets Cramer's goat is when CEOs create a false opportunity through buybacks. And he's not talking about your local bartender giving you a free beer.
Cramer is wholeheartedly in agreement that it is a great idea to grow a business by putting more money into it, if your business needs the cash to grow.
But it seems like these days that most companies are creating a buyback or dividend because they don't have any other opportunities available for shareholders. So rather than create value internally, they look to create value by announcing a buyback. Is that such a bad thing though?
Yahoo, for example, has made many good investments under the guidance of Marissa Mayer. She did it by strategic acquisitions and focusing on growth the business. Apple is also another great success story.
"If there were some powerful, winning initiatives that could really move the needle, I am quite confident that Apple would seize them," Cramer added.
Opportunities were also pointed out in the Lightning Round, when Cramer fired off his take on a few callers' favorite stocks:
Cliffs Natural Resources: "My charitable trust owns Valet, and it's been one of the worst disasters we have ever had. You always have to own the good ones and the bad ones, and this one has been a terrible one. I do not want you in Cliff."
IMS Health Holdings: "It's okay. I prefer Quintiles if you want to get into that kind of service business, and I even prefer McKesson. I think both are better."
Read MoreLightning Round: Do not own this